Discover Algeria | Press area | Contact  
English Français
Registration
English Français

September 9, 2024 | 4 months ago

  • More options

    Share on LinkedIn
    Share on Twitter

Saidal Group acquires WPS production site

As part of the strengthening of its strategic partnership with Sanofi, the Saidal Group has taken over the WPS production site in Oued Smar. Created in 1998 as part of a joint venture between Saidal and Sanofi Laboratories, the site is now entering a new phase of development led by the Algerian pharmaceutical group.

Algeria Invest
Legal Notices | Terms of Services
news-detail

This acquisition is part of Saidal's ambitious growth plan, aimed at boosting its production capacity and diversifying its drug offering in Algeria. The partnership between the two pharmaceutical giants has lasted almost 25 years, with a successful collaboration that began with the production of part of Sanofi's therapeutic portfolio in Algeria.

 

On June 25, 2024, both companies signed a new agreement to produce insulins, starting in the same year. This partnership will enable to provide Algerian patients with innovative therapeutic solutions, while ensuring their long-term availability and reducing healthcare costs. In addition to insulins, this agreement also includes production of the Hexavalent pediatric vaccine, monoclonal antibodies, and several latest-generation anti-cancer drugs.

 

Thanks to this takeover and the extension of their collaboration, Saidal and Sanofi are reasserting their commitment to strengthening local drug production and meeting the growing needs of the Algerian market.

September 9, 2024 | algeria-logo

  • More options

    Share on LinkedIn
    Share on Twitter
Subscribe to the economic newsletter